Vertex Pharmaceuticals Inc / Ma

Rhenman & Partners Asset Management AB VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

34,255

Value ($000)

15,530

Weight

1.5%

2014 Q2 - 2025 Q4 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	15,530	1.5%	34,255	12/31/2025
2025 Q3	11/13/2025	18,389	2.0%	46,955	9/30/2025
2025 Q2	8/13/2025	27,360	3.5%	61,455	6/30/2025
2014 Q2	7/31/2014	9,619	2.9%	101,600	6/30/2014